Advanced search
Publication Cover
Acta Oncologica Volume 41, 2002 - Issue 2
Journal homepage
238
Views
54
CrossRef citations to date
0
Altmetric
Research Article

Trends in Incidence of Cutaneous Malignant Melanoma in a Swedish Population 1976-1994

Eva Månsson-Brahme From the Department of Oncology, Radiumhemmet, Karolinska Hospital, (E. Ma nsson-Brahme, U. Ringborg), Department of Oncology, Huddinge University Hospital, (H. Johansson, L. E. Rutqvist) and the Department of Pathology, Karolinska Hospital (O. Larsson), Stockholm, Sweden
,
Hemming Johansson From the Department of Oncology, Radiumhemmet, Karolinska Hospital, (E. Ma nsson-Brahme, U. Ringborg), Department of Oncology, Huddinge University Hospital, (H. Johansson, L. E. Rutqvist) and the Department of Pathology, Karolinska Hospital (O. Larsson), Stockholm, Sweden
,
Olle Larsson From the Department of Oncology, Radiumhemmet, Karolinska Hospital, (E. Ma nsson-Brahme, U. Ringborg), Department of Oncology, Huddinge University Hospital, (H. Johansson, L. E. Rutqvist) and the Department of Pathology, Karolinska Hospital (O. Larsson), Stockholm, Sweden
,
Lars E. Rutqvist From the Department of Oncology, Radiumhemmet, Karolinska Hospital, (E. Ma nsson-Brahme, U. Ringborg), Department of Oncology, Huddinge University Hospital, (H. Johansson, L. E. Rutqvist) and the Department of Pathology, Karolinska Hospital (O. Larsson), Stockholm, Sweden
&
Ulrik Ringborg From the Department of Oncology, Radiumhemmet, Karolinska Hospital, (E. Ma nsson-Brahme, U. Ringborg), Department of Oncology, Huddinge University Hospital, (H. Johansson, L. E. Rutqvist) and the Department of Pathology, Karolinska Hospital (O. Larsson), Stockholm, Sweden
Pages 138-146 | Published online: 08 Jul 2009

  • Cancer incidence in Sweden 1999. Stockholm: The National Board of Health and Welfare. Centre for Epidemiology, 2001.
  • MacLennan R, Green AC, McLeod GR, Martin NG. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 1992; 84: 1427-32.
  • MacKie RM, Hole D, Hunter JA, et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. Br Med J 1997; 315: 1117 -21.
  • Dennis LK. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Derma-tol 1999; 135: 275-80.
  • Burton RC, Coates MS, Hersey P, et al. An analysis of a melanoma epidemic. Int J Cancer 1993; 55: 765-70.
  • La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 1999; 81: 62-6.
  • Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000; 82: 1887-91.
  • Giles GG, Armstrong BK, Burton RC, Staples MP, Thurs? eld VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. Br Med J 1996; 312: 1121-5.
  • Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE, Larsson O, Johansson H, Ringborg U. Trends in mortality from malignant melanoma in Sweden, 1970-1996. Cancer 2000;89:348-55.
  • Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001; 93: 678-83.
  • Malec E, Eklund G, Lagerlof B. Re-appraisal of malignant melanoma diagnosis in the Swedish cancer registry. Acta Pathol Microbiol Scand [A] 1977; 85: 707 -12.
  • Thorn M, Bergstrom R, Adami HO, Ringborg U. Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984. Am J Epidemiol 1990; 132: 1066-77.
  • Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO. Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden. Br J Cancer 1994; 70: 743-8.
  • Masback A, Westerdahl J, Ingvar C, Olsson H, Jonsson N. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review. Cancer 1994; 73: 1625-30.
  • Ringborg U, Lagerlof B, Broberg M, Mansson-Brahme E, Platz A, Thorn M. Early detection and prevention of cutaneous malignant melanoma: emphasis on Swedish activities. Med Oncol Tumor Pharmacother 1991; 8: 183-7.
  • Ringborg U, Lagerlof B, Beitner H, Molin L, Rorsman H, Swanbeck G. [The Open House campaign for skin examinations resulted in valuable experiences]. Lakartidningen 1992; 89: 1484 -5.
  • Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-noti? ed cancer cases recorded on death certi? cates in 1978. Acta Radiol Oncol 1984; 23: 305-13.
  • Clark WH, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29: 705-27.
  • Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902-8.
  • Cochran AJ, Bailly C, Paul E, Remotti F. Melanocytic tumors. A guide to diagnosis. Philadelphia: Lippincott-Raven, 1997:325-9.
  • McGovern VJ, Cochran AJ, Van der Esch EP, Little JH, MacLennan R. The classi? cation of malignant melanoma, its histological reporting and registration: a revision of the 1972 Sydney classi? cation. Pathology 1986; 18: 12 -21.
  • McNeer G, Das Gupta TK. Prognosis in malignant melanoma. Surgery 1964; 56: 512- 8.
  • Ringborg U. Cutaneous malignant melanoma.State of the art. MARS. Stockholm: The National Board of Health and Welfare, 2001.
  • Fleiss JL. The standardisation of rates. In: Statistical methods for rates and proportions, 2nd ed. New York: John Wiley and Sons, 1981: 237-55.
  • Clayton D, Schif? ers E. Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 1987;6:449-67.
  • Clayton D, Schif? ers E. Models for temporal variation in cancer rates. II: age-period-cohort models. Stat Med 1987; 6: 469 -81.
  • Francis B, Green M, Payne C. The GLIM system: generalized linear interactive modelling. In: Manual, release, 4th ed. Oxford: Clarendon Press, 1993.
  • MacKie RM. Secondary prevention of cutaneous malignant melanoma. Melanoma Res 1997; 7 (Suppl 2): S151-4.
  • Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997; 73: 198-203.
  • Bulliard JL, Cox B, Semenciw R. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93. Cancer Causes Control 1999; 10: 407-16.
  • Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer 2001; 92: 457-62.
  • Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001; 12: 69 -82.
  • Philipp R, Hastings A, Briggs J, Sizer J. Are malignant melanoma time trends explained by changes in histopathological criteria for classifying pigmented skin lesions? J Epi-demiol Community Health 1988; 42: 14 -6.
  • van der Esch EP, Muir CS, Nectoux J, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991; 47: 483 -9.
  • Thorn M, Sparen P, Bergstrom R, Adami HO. Trends in mortality rates from malignant melanoma in Sweden 1953-1987 and forecasts up to 2007. Br J Cancer 1992; 66: 563 -7.
  • MacKie R, Hunter JA, Aitchison TC, et al. Cutaneous malignant melanoma, Scotland, 1979 -89. Lancet 1992; 339: 971-5.
  • Holman CD, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984; 73:75-82.
  • Elwood JM, Gallagher RP, Worth AJ, Wood WS, Pearson JC. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study. J Natl Cancer Inst 1987; 78: 37-44.
  • Harrison SL, MacLennan R, Speare R, Wronski I. Sun exposure and melanocytic naevi in young Australian children. Lancet 1994; 344: 1529 -32.
  • Autier P, Dore JF, Cattaruzza MS, et al. Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. J Natl Cancer Inst 1998; 90: 1873-80.
  • Clark WH, Reimer RR, Greene M, Ainsworth AM, Mas-trangelo MJ. Origin of familial malignant melanomas from heritable melanocytic lesions. The B–K mole syndrome Arch Dermatol 1978; 114: 732-8.
  • Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995; 33: 1000-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.